Safari Flower Company Achieves EU-GMP Certification for Medical Cannabis Production

Safari Flower Company Achieves EU-GMP Certification

In a significant development for the medical cannabis industry, Safari Flower Company, a fully owned subsidiary of Aurora Cannabis Inc., proudly announces that it has secured the prestigious European Union Good Manufacturing Practice (EU-GMP) certification for its Niagara facility in Ontario, Canada. This accomplishment solidifies the company’s capability to cater to the international medical cannabis markets, particularly those in Europe, which are governed by some of the strictest regulations in the industry.

Receiving the EU-GMP certification is a testament to Safari's unwavering commitment to quality, compliance, and operational excellence, as emphasized by Brigitte Simons, CEO of Safari Flower Company. In her statement, Simons expressed pride in achieving this high standard, reinforcing the company's position as a trusted provider of high-quality medical cannabis. She stated, "This milestone reflects the strong culture of compliance, quality and operational excellence embedded across our facility. It further positions Safari to support the evolving needs of medical cannabis markets globally."

The Niagara facility spans 59,000 square feet, designed specifically for cultivation and manufacturing. The facility has a proven history of EU-GMP accreditation and is prepared to meet the increasing demands of international markets in countries like Germany, Poland, and the UK. In April 2026, Aurora Cannabis acquired Safari Flower Company to augment its EU-GMP capabilities and enhance its global manufacturing network, further committing to supply high-quality medical cannabis worldwide.

As the international medical cannabis landscape evolves, maintaining EU-GMP certification is crucial for Safari. It serves as an essential enabler of the company's ability to confidently serve regulated markets that prioritize rigorous quality, safety, and compliance standards. The firm is proud to be a supplier that meets the rapidly growing demands for medical cannabis products while adhering to stringent protocols.

In addition to focusing on domestic markets, Safari Flower Company is dedicated to expanding its footprint internationally. This certification represents an important step towards meeting the intricate needs of patients and healthcare providers who rely on trustworthy medical cannabis products. With continued advancements in the realm of cannabis cultivation and manufacturing, the commitment to produce safe and effective products remains a priority for Safari.

Safari Flower Company’s promise is backed by the broader vision of Aurora Cannabis, a leader in the medical cannabis sector globally. Aurora has a significant presence across several regions, including North America, Europe, Australia, and New Zealand, offering a diverse portfolio of recognized brands such as Aurora®, MedReleaf®, and Pedanios® among others. The overarching goal of the company is clear: to improve patients' lives through scientific excellence and reliable service.

As Aurora Cannabis continues to expand its global network with EU-GMP-certified facilities in Canada and Germany, the team is set to maintain and elevate the standard of quality in the cannabis industry. With this certification, Safari Flower Company can enhance its role in supporting healthcare systems worldwide and contributing to patients' access to quality medical cannabis products.

For more information about Safari Flower Company and its mission, visit Aurora Cannabis's official website.